Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitubercular Agents”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Testing effectiveness (Phase 2)Looking for participantsNCT07303699
What this trial is testing

ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)

Who this might be right for
Pulmonary Tuberculosis (TB)
Obafemi Awolowo University Teaching Hospital 80
Early research (Phase 1)Study completedNCT02128308
What this trial is testing

Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents

Who this might be right for
Healthy
Seoul National University Hospital 16
Testing effectiveness (Phase 2)Study completedNCT00685360
What this trial is testing

A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug ResistantExtensively Drug-Resistant Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 481
Not applicableEnded earlyNCT01381757
What this trial is testing

Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali

Who this might be right for
Tuberculosis, PulmonaryMycobacterium TuberculousAntitubercular Agents+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 34
Early research (Phase 1)Study completedNCT01162486
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers

Who this might be right for
TuberculosisTuberculosis, Pulmonary
Johns Hopkins University 37
Large-scale testing (Phase 3)Ended earlyNCT06418711
What this trial is testing

ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

Who this might be right for
MAC Lung DiseaseTreatment Refractory MAC Lung DiseaseMycobacterium Infections, Nontuberculous
Mannkind Corporation 132
Testing effectiveness (Phase 2)Study completedNCT03959566
What this trial is testing

PanACEA Sutezolid Dose-finding and Combination Evaluation

Who this might be right for
Pulmonary TuberculosisOther Specified Pulmonary Tuberculosis
Michael Hoelscher 75
Large-scale testing (Phase 3)UnknownNCT04117698
What this trial is testing

Multicenter, Randomized Study Evaluating the Value of Antitubercular Treatment During Recurent Anterior Uveitis (URBA)

Who this might be right for
Uveitis, Anterior
Assistance Publique - Hôpitaux de Paris 116
Not applicableStudy completedNCT00000950
What this trial is testing

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableStudy completedNCT00096850
What this trial is testing

Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 18
Not applicableStudy completedNCT00000636
What this trial is testing

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 2,000
Not applicableStudy completedNCT00000959
What this trial is testing

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 600
Not applicableStudy completedNCT00000947
What this trial is testing

Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 850
Testing effectiveness (Phase 2)Study completedNCT05382312
What this trial is testing

Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
GlaxoSmithKline 127
Testing effectiveness (Phase 2)Study completedNCT02371681
What this trial is testing

NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 262
Not applicableStudy completedNCT00002032
What this trial is testing

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
Pharmacia 750
Testing effectiveness (Phase 2)Looking for participantsNCT05807399
What this trial is testing

PanACEA - STEP2C -01

Who this might be right for
Pulmonary TuberculosisOther Specified Pulmonary Tuberculosis
Michael Hoelscher 390
Large-scale testing (Phase 3)Looking for participantsNCT06253715
What this trial is testing

Shortened Regimen for Drug-susceptible TB in Children

Who this might be right for
TuberculosisTuberculosis, PulmonaryTuberculosis, Lymph Node+1 more
Johns Hopkins University 860
Early research (Phase 1)Study completedNCT03423030
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation

Who this might be right for
TuberculosisTuberculosis, Pulmonary
Innovative Medicines for Tuberculosis 32
Testing effectiveness (Phase 2)UnknownNCT05926466
What this trial is testing

BTZ-043 Dose Evaluation in Combination and Selection

Who this might be right for
Tuberculosis, PulmonaryOther Specified Pulmonary Tuberculosis
Michael Hoelscher 90
Load More Results